Study backs increased PSA screening for younger African Americans

Urology Times staff

Study results presented during the 2021 ASCO Annual Meeting showed an association between increased prostate-specific antigen (PSA) screening and improved outcomes in younger African American patients.

In this video, lead study author Edmund M. Qiao, a medical student at the University of California San Diego, discusses how the results show that in younger African Americans, an increase in the frequency of PSA screening was linked to a nearly 25% reduction in prostate cancer–specific mortality and an approximately 40% lower risk of having metastatic disease at the time of a prostate cancer diagnosis. Based on their findings, the researchers recommend that younger African Americans begin having discussions early with their physicians regarding whether they need screening.